Browse 24807 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
July 1st, 2020 |
Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 7th, 2020 |
Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional) |
National Institutes of Health |
October 3rd, 2022 |
BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) |
National Institutes of Health |
June 26th, 2020 |
Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required) |
National Institutes of Health |
July 28th, 2020 |
FY2020 Title X Services Grants: Providing Publicly-Funded Family Planning Services in Areas of High Need |
Office of the Assistant Secretary for Health |
February 28th, 2020 |
National Peer-Run Training and TA Center for Addiction Recovery Peer Support |
Substance Abuse and Mental Health Services Adminis |
February 28th, 2020 |
Family Support Technical Assistance Center |
Substance Abuse and Mental Health Services Adminis |
June 30th, 2020 |
White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed) |
National Institutes of Health |
July 5th, 2022 |
Surgical Disparities Research (R01 - Clinical Trial Optional) |
National Institutes of Health |
February 28th, 2020 |
Homeless and Housing Resource Center |
Substance Abuse and Mental Health Services Adminis |
February 27th, 2020 |
Maintaining and Strengthening Institutional Capacity of Maputo City Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 16th, 2020 |
Malaria Operations Research to Improve Malaria Control and Reduce Morbidity and Mortality in Western Kenya |
Centers for Disease Control and Prevention ERA |
June 29th, 2020 |
Strategies to Maintain HIV Viral Suppression Among State Prison Inmates Released to the Community |
Centers for Disease Control NCHHSTP |
March 13th, 2020 |
Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations (R21- Clinical Trials Not Allowed) |
National Institutes of Health |
February 21st, 2020 |
Maintaining and Strengthening Institutional Capacity of Maputo Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
March 27th, 2020 |
Support HIV/AIDS Prevention, Care, and Treatment Activities for Mothers, Children, and Families under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
February 24th, 2020 |
Strengthening the Zambia Ministry of Health's Capacity to Provide Leadership to the National HIV/AIDS Response through Coordination, Policy Development, Mentorship and Training under the President's Emergency Plan for |
Centers for Disease Control CGH |
February 20th, 2020 |
Support and Capacity Building for Polio Eradication, Control of Other Vaccine Preventable Diseases, and Immunization Systems Strengthening in Africa. |
Centers for Disease Control CGH |
September 29th, 2020 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) |
National Institutes of Health |
September 29th, 2020 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
National Institutes of Health |
|
September 29th, 2020 |
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
National Institutes of Health |
September 29th, 2020 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
National Institutes of Health |
March 17th, 2020 |
Limited Competition: 4DN Organizational Hub (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 17th, 2020 |
Limited Competition 4DN Data Coordination and Integration Center (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 6th, 2020 |
Nurse Anesthetist Traineeships (NAT) |
Health Resources and Services Administration |
September 29th, 2020 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
National Institutes of Health |
September 29th, 2020 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
National Institutes of Health |
February 3rd, 2020 |
Eliminate Tuberculosis from Ethiopia |
Ethiopia USAID Addis Ababa |
February 19th, 2020 |
Strengthening Community-Based HIV Prevention and Response and Supporting Scale Up of Index Testing and Tracing of Patients Lost to Follow Up and Mother-Infant Pairs in Zambia under the President's Emergency Plan for |
Centers for Disease Control CGH |
February 19th, 2020 |
Maintaining and Strengthening Institutional Capacity of Cabo Delgado Province Health Directorate in Mozambique under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
November 25th, 2022 |
Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
March 18th, 2020 |
Enhancing Engagement of People with HIV through Organizational Capacity Development and Leadership Training (E2tDLT) |
Health Resources and Services Administration |
February 13th, 2020 |
Police and Prisons Activity |
Tanzania USAID Dar es Salaam |
July 1st, 2020 |
Novel Therapeutics Directed to Intracellular HIV Targets (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
March 5th, 2020 |
Scaling up and Improving Quality of Civil Registration and Vital Statistics in Malawi Through the National Registration Bureau under the President's Emergency Plan for AIDS Relief (PEPFAR) |
Centers for Disease Control CGH |
January 17th, 2020 |
Achieving and Sustaining HIV Epidemic Control Activities (AS-HIV-ECA) 2020-2025 |
Ethiopia USAID Addis Ababa |
March 10th, 2020 |
Develop, Implement, and Evaluate Evidence-based, Innovative Approaches to Prevent, Find, and Cure Tuberculosis in High-Burden Settings |
Centers for Disease Control and Prevention ERA |
June 17th, 2020 |
Mechanisms of Rejuvenation and Age-Acceleration in Heterochronic Blood Exchange (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 17th, 2020 |
Glial Plasticity in the Aging Brain (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
June 30th, 2020 |
Developmental Mechanisms of Human Structural Birth Defects (P01 Clinical Trial Not Allowed)) |
National Institutes of Health |